(Health-NewsWire.Net, July 18, 2020 ) Bioprocess containers are single-use flexible container systems that are utilized in the upstream and downstream processes for sterile liquid-handling applications in the biopharmaceutical industry. These containers are employed in the preparation of cell-media and are a cost-effective alternative to conventional stainless-steel systems.
The global bioprocess containers market is expected to reach USD 1,914.6 million by 2023 from USD 913.3 million in 2017, at a CAGR of 13.2%. The base year considered for the study is 2017, and the forecast for the market is provided for the period between 2018 and 2023.
Growth in the bioprocess containers market is mainly driven by factors such as the increasing demand for biologics, affordability and sustainability of single-use bioprocess technologies, vaccine production using single-use disposable technologies, and the lower risk of cross-contamination. The booming biopharma industry in emerging countries is also expected to offer a wide range of growth opportunities to players in the market. On the other hand, issues related to leachable and extractables and increasing market consolidation are expected to challenge market growth to a certain extent during the forecast period.
Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107645832
Market Dynamics
Driver: Rising Demand for Low-Cost Biologic Drugs
At present, there is a rising demand for low-cost biologic drugs. A major factor driving the biologics market is the rapidly increasing global geriatric population. According to the US Census Bureau, in 2015, an estimated 8.5% (or 617.1 million individuals) of the global population was aged 65 years and older; by 2030, this figure is estimated to reach 22%. In the same year, the aging population accounted for 18.6% of the total population in the US and 18.9% of the total population in Europe. With growth in the aging population across major markets globally, the demand for biopharmaceuticals is expected to increase as the elderly are more prone to diseases such as diabetes, hypertension, musculoskeletal and cardiovascular diseases, chronic kidney diseases, stroke, and cancer.
Opportunity: Booming Emerging Markets
China, India, Japan, Korea, and Brazil are emerging markets for single use bioprocessing systems. These markets lack proper standards and government regulations and thus offer significant growth potential for providers that are unable to meet the stringent regulatory standards in the US and European Union (EU). High investments in bio-manufacturing infrastructures are another key factor responsible for the high-growth potential of these markets. For instance, in November 2014, Amgen announced the opening of a USD 200-million bio-manufacturing facility in Singapore to expand its bio-manufacturing capabilities for monoclonal antibodies. For this facility, Amgen adopted single-use systems in 90% of the plant’s operations.
Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=107645832
North America is estimated to command the largest share of the market
North America accounted for the largest share of this market in 2017, followed by Europe. The rising demand for biopharmaceuticals and advantages associated with the use of bioprocess bags such as their energy efficiency, decreased risk of product cross contamination, and fast implementation are driving the adoption of bioprocess containers in North America. The US accounted for the largest share of the North American bioprocess market in 2017. The growing focus on biopharmaceutical production is a major driver for this market. Government support for novel biologics production has triggered R&D activity in the country, thereby making it an attractive destination for biologics manufacturing.
The key players in the bioprocess containers market are Thermo Fisher Scientific (US), Sartorius (Germany), GE Healthcare (US), Merck KGaA (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Meissner (US), Rim Bio (US), and Fluids Control (Argentina).
Critical questions the report answers:
What are the growth opportunities in the bioprocess containers market across major regions in the future? Emerging countries have immense opportunities for the growth and adoption of bioprocess containers. Will this scenario continue during the next five years? Where will all the advancements in products offered by various companies take the industry in the mid- to long-term? What are the various bioprocess containers types and their respective market shares in the overall market? What are the new trends and advancements in the bioprocessing market?
Inquiry before Buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=107645832
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com
|